Lv1
48 积分 2025-08-28 加入
Should We Be Concerned About Glucagon-Like Peptide-1 Receptor Agonists?
1个月前
已完结
Glucagon-Like Peptide-1 Receptor Agonist Use and Age-Related Macular Degeneration—Where Do We Stand?
3个月前
已关闭
Talks and tweets from the ADA
5个月前
已完结
Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes
5个月前
已完结
GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
5个月前
已完结
Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma
6个月前
已完结
IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
7个月前
已完结
Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems
9个月前
已完结
Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma
9个月前
已完结
Visual Outcomes and Optical Quality of Accommodative, Multifocal, Extended Depth-of-Focus, and Monofocal Intraocular Lenses in Presbyopia-Correcting Cataract Surgery
9个月前
已完结
皖公网安备34019202002308
